CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	6 Months Ended
Jun. 30, 2013	Jun. 30, 2012
Cash flows from operating activities:
Net income	$ 151,576	$ 24,290
Adjustments to reconcile net income to net cash provided by operating activities:
Provision (credit) for loan and lease losses	(6,788)	(11,620)
Depreciation and amortization	3,027	3,120
Write down of assets		1,759
Write down of other real estate, net of gain on sale	(7,739)	1,416
Amortization of other intangible assets	4,357	4,792
Net amortization of investment securities	7,618	7,304
Share-based compensation	1,606	1,348
Net gain on sales of residential loans	(7,016)	(6,371)
Proceeds from sales of loans held for sale	398,955	411,200
Originations of loans held for sale	(368,330)	(387,400)
Equity in earnings of unconsolidated subsidiaries	(220)	(215)
Increase in cash surrender value of bank-owned life insurance	(881)	(3,462)
Deferred income taxes	(117,857)
Net change in other assets and liabilities	17,240	(18,064)
Net cash provided by operating activities	75,548	28,097
Cash flows from investing activities:
Proceeds from maturities of and calls on investment securities available for sale	289,045	170,511
Proceeds from sales of investment securities available for sale		2,695
Purchases of investment securities available for sale	(414,486)	(321,821)
Proceeds from maturities of and calls on investment securities held to maturity	6,174	441
Net loan originations	(149,091)	(45,839)
Purchase of loan portfolio	(26,235)
Proceeds from sales of loans originated for investment	460	782
Proceeds from sale of other real estate	14,205	12,848
Proceeds from bank-owned life insurance		1,446
Purchases of premises and equipment	(3,075)	(1,901)
Distributions from unconsolidated subsidiaries	550	434
Contributions to unconsolidated subsidiaries	(9,050)
Proceeds from redemption of FHLB stock	869
Net cash used in investing activities	(290,634)	(180,404)
Cash flows from financing activities:
Net increase in deposits	174,894	118,789
Repayments of long-term debt	(9)	(50,009)
Net decrease in short-term borrowings		(34)
Net cash provided by financing activities	174,885	68,746
Net decrease in cash and cash equivalents	(40,201)	(83,561)
Cash and cash equivalents at beginning of period	177,375	257,072
Cash and cash equivalents at end of period	137,174	173,511
Cash paid during the period for:
Interest	15,666	3,228
Income taxes	5	1
Cash received during the period for:
Income taxes		11
Supplemental disclosure of noncash investing and financing activities:
Net change in common stock held by directors' deferred compensation plan	39	27
Net reclassification of loans to other real estate	3,217	1,962
Net transfer of loans to loans held for sale		290
Net transfer of investment securities available for sale to held to maturity	$ 101,669

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets, and the amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.

No definition available.